18522500. POLARIZED LIGHT-EMITTING PARTICLES FOR SPECIMEN TEST simplified abstract (CANON KABUSHIKI KAISHA)
Contents
- 1 POLARIZED LIGHT-EMITTING PARTICLES FOR SPECIMEN TEST
- 1.1 Organization Name
- 1.2 Inventor(s)
- 1.3 POLARIZED LIGHT-EMITTING PARTICLES FOR SPECIMEN TEST - A simplified explanation of the abstract
- 1.4 Simplified Explanation
- 1.5 Potential Applications
- 1.6 Problems Solved
- 1.7 Benefits
- 1.8 Potential Commercial Applications
- 1.9 Possible Prior Art
- 1.10 Original Abstract Submitted
POLARIZED LIGHT-EMITTING PARTICLES FOR SPECIMEN TEST
Organization Name
Inventor(s)
NORISHIGE Kakegawa of Tokyo (JP)
TAKAHIRO Masumura of Tochigi (JP)
TEIGO Sakakibara of Tokyo (JP)
FUMIO Yamauchi of Kanagawa (JP)
KENGO Kanazaki of Kanagawa (JP)
POLARIZED LIGHT-EMITTING PARTICLES FOR SPECIMEN TEST - A simplified explanation of the abstract
This abstract first appeared for US patent application 18522500 titled 'POLARIZED LIGHT-EMITTING PARTICLES FOR SPECIMEN TEST
Simplified Explanation
The patent application describes a particle with high detection sensitivity for measuring substances such as antigens or antibodies in the body. The particle contains a rare earth complex, has a particle size distribution of 0.1 or less in terms of polydispersity index, and has a hydrophilic polymer on its surface.
- Rare earth complex particle with high detection sensitivity
- Particle size distribution of 0.1 or less in terms of polydispersity index
- Hydrophilic polymer coating on the particle surface
Potential Applications
The technology could be used in various fields such as medical diagnostics, environmental monitoring, and food safety testing.
Problems Solved
This technology addresses the need for highly sensitive detection of substances in the body, which is crucial for early diagnosis and monitoring of diseases.
Benefits
- Improved accuracy in measuring substances - Early detection of diseases - Enhanced sensitivity in detection methods
Potential Commercial Applications
The technology could be applied in medical device manufacturing, biotechnology companies, and research institutions for developing advanced diagnostic tools.
Possible Prior Art
One possible prior art could be the use of nanoparticles for sensitive detection of substances in biological samples. However, the specific combination of a rare earth complex, particle size distribution, and hydrophilic polymer coating as described in this patent application may be novel.
Unanswered Questions
How does this technology compare to existing detection methods in terms of sensitivity and accuracy?
This article does not provide a direct comparison with existing detection methods to evaluate the performance of the new technology.
What are the potential limitations or challenges in implementing this technology in real-world applications?
The article does not discuss any potential limitations or challenges that may arise when applying this technology in practical settings.
Original Abstract Submitted
Provided is a particle having high detection sensitivity in the detection of a substance to be measured, such as an antigen or an antibody, from a body. The particle includes a rare earth complex, wherein the particle has a particle size distribution of 0.1 or less in terms of polydispersity index (pdi) measured by dynamic light scattering, and wherein the particle has a hydrophilic polymer on a surface thereof.
